The Clinical Impact of an Aggressive Approach Towards Pleural and Pericardial Effusions Following Open Heart Surgery: a Step Towards Standard Guidelines
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Heart Disease
- Sponsor
- Aarhus University Hospital Skejby
- Enrollment
- 76
- Locations
- 1
- Primary Endpoint
- change in walking distance before and after intervention
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
One of the most common postoperative complications after open cardiac surgery is fluid accumulation between the pleural membranes or in the pericardial sac. This study investigates the consequence of such fluid accumulations on physical performance, recovery-time, cardiac and respiratory complications, and quality of life. Half of the participants will be followed closely and offered fluid drainage at a low threshold, and half of the participants will follow the current postoperative regimen.
Detailed Description
Introduction: Knowledge concerning the impact of pleural and pericardial effusions on physical performance, recovery-time, cardiac and respiratory complications, and quality of life after open cardiac surgery is scarce. A more aggressive approach towards effusions has been suggested, but further studies are needed. Objectives: 1. to determine the size of pleural and pericardial effusion that results in at least 30% reduction of physical performance in the 6-minute walk test. 2. to compare the improvement in physical performance between the intervention group and the control group, measured from baseline to day 30 after surgery. Materials and methods: A randomised controlled intervention trial. Patients admitted for open cardiac surgery (aortic valve surgery, coronary artery bypass graft surgery and combinations) will be randomised into either an intervention group or a control group. The intervention group will be followed with physical tests and ultrasonic examination the month following surgery. Pleural or pericardial effusion of a predefined size will be drained. The control group will follow the current postoperative regimen.
Investigators
Laura Sommer Hansen
MD PHD fellow
Aarhus University Hospital Skejby
Eligibility Criteria
Inclusion Criteria
- •Age \>18 years.
- •Admitted for elective aortic valve surgery, coronary artery bypass graft surgery or combinations.
- •Be able to understand the written and oral patient information and to give informed consent.
Exclusion Criteria
- •Surgical combinations involving the mitral valve since they are already examined with full echocardiography prior to discharge, which may influence protocol driven decisions.
- •Simultaneous participation in any other clinical intervention trial
Outcomes
Primary Outcomes
change in walking distance before and after intervention
Time Frame: day 4, day 15, day 30
The primary outcome measure is the change in walking distance before and after pleuracentesis, subsequently the size of pleural effusion (both cm measured on ultrasound and drained volume) that results in a reduction of distance in the 6 minute walk test of at least 30%.
Secondary Outcomes
- change in walking distance from baseline to day 30 after surgery(day 0 and day 30)